Researchers have found that AS-IV can suppress HCC through the regulation of the pSmad3C/3L and nuclear factor erythroid 2-related factor 2/Heme Oxygenase 1 (Nrf2/HO-1) pathways [248]. The gene discussed is NFE2L2; the disease is hepatocellular carcinoma.